Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Major Depressive Disorder Patients”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Post-approval studies (Phase 4)Study completedNCT03207438
What this trial is testing

Melancholic Depression and Insomnia as Predictors of Response to Quetiapine in Patients With Major Depression

Who this might be right for
Depressive Disorder, Major
University of Saskatchewan 1,790
Large-scale testing (Phase 3)Study completedNCT01157078
What this trial is testing

Assess the Efficacy and Safety of TC-5214 as an Adjunct Therapy in Patients With Major Depressive Disorder (MDD)

Who this might be right for
Major Depressive DisorderDepression
AstraZeneca 319
Early research (Phase 1)Study completedNCT06920238
What this trial is testing

Use of a Generative AI (Gen-AI) Chatbot for Anxiety and Depression Among Persons With Cannabis Use

Who this might be right for
Cannabis Use DisorderAnxietyDepression, Anxiety+1 more
Trustees of Dartmouth College 15
Not applicableUnknownNCT05106868
What this trial is testing

Acupuncture for Patients With Major Depressive Disorder

Who this might be right for
Major Depressive Disorder
Chengdu University of Traditional Chinese Medicine 123
Post-approval studies (Phase 4)UnknownNCT00442481
What this trial is testing

Escitalopram and Sleep Architecture in Patients With Major Depressive Disorder

Who this might be right for
Major Depressive Disorder
Sheba Medical Center 25
Post-approval studies (Phase 4)Study completedNCT00384436
What this trial is testing

Fixed Dose Comparison of Escitalopram to an Active Comparator in Severely Depressed Patients

Who this might be right for
Major Depressive Disorder
Forest Laboratories 580
Not applicableStudy completedNCT05932407
What this trial is testing

A Database Survey of Comparison The Risk of Haemorrhage Between Vortioxetine Tablet Treatment and Selective Serotonin Reuptake Inhibitor (SSRI) Treatment in Participants With Depression

Who this might be right for
Major Depressive Disorder
Takeda 147,777
Large-scale testing (Phase 3)Study completedNCT00109044
What this trial is testing

Comparison of Escitalopram Combination in Adult Patients With Major Depressive Disorder

Who this might be right for
Major Depressive Disorder
Forest Laboratories 540
Large-scale testing (Phase 3)Study completedNCT00629551
What this trial is testing

An Eight-week Study of Saredutant and Paroxetine as Combination Treatment for Major Depressive Disorder

Who this might be right for
Depressive Disorder, Major
Sanofi 825
Post-approval studies (Phase 4)Study completedNCT00237666
What this trial is testing

Open-Label Study of Geodon in Non-Rapid Cycling Bipolar II Patients With Major Depression

Who this might be right for
Bipolar II DisorderMajor Depressive Episode
The Medical Research Network 30
Testing effectiveness (Phase 2)Study completedNCT05220410
What this trial is testing

The Safety and Efficacy of Psilocybin in Patients With Treatment-resistant Depression and Chronic Suicidal Ideation

Who this might be right for
Treatment Resistant DepressionSuicidal Ideation
Sheppard Pratt Health System 20
Not applicableStudy completedNCT04680611
What this trial is testing

Severe Asthma, MepolizumaB and Affect: SAMBA Study

Who this might be right for
Severe Eosinophilic AsthmaPsychological DistressAnxiety+14 more
University Hospital Southampton NHS Foundation Trust 120
Large-scale testing (Phase 3)Study completedNCT00073411
What this trial is testing

Duloxetine Compared to Escitalopram and Placebo in the Treatment of Patients With Depression

Who this might be right for
Depression
Eli Lilly and Company 675
Large-scale testing (Phase 3)Ended earlyNCT04260607
What this trial is testing

Initiating Ketamine in Acutely Suicidal Patients in the Emergency Department

Who this might be right for
SuicideSuicide ThreatDepression Severe
Naval Medical Center Camp Lejeune 1
Testing effectiveness (Phase 2)UnknownNCT04971291
What this trial is testing

An Evaluation of AXS-05 for the Treatment of TRD in Treatment-Adherent Patients

Who this might be right for
Major Depressive DisorderTreatment Resistant Depression
Axsome Therapeutics, Inc. 312
Testing effectiveness (Phase 2)Study completedNCT04979910
What this trial is testing

Targeting IL-17A for Treatment-Resistant Depression

Who this might be right for
Major Depressive Disorder
Icahn School of Medicine at Mount Sinai 7
Not applicableUnknownNCT04124276
What this trial is testing

Evaluation of Efficacy of Lycium Barbarum Polysaccharide in Patients With Major Depressive Disorder

Who this might be right for
Major Depressive DisorderDepressionDepressive Disorder
Guangzhou Psychiatric Hospital 284
Testing effectiveness (Phase 2)Study completedNCT04521478
What this trial is testing

Test the Effect of Different Doses of BI 1358894 and Quetiapine in People With Depression

Who this might be right for
Depressive Disorder, Major
Boehringer Ingelheim 389
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07373535
What this trial is testing

Understanding Music and Mindfulness Preferences in Psilocybin-Assisted Psychotherapy

Who this might be right for
Treatment-Resistant Major Depressive Disorder
Kyle Greenway 16
Large-scale testing (Phase 3)Study completedNCT03738215
What this trial is testing

Efficacy, Safety and Tolerability of Cariprazine as an Adjunctive Treatment to Antidepressant Therapy (ADT) in Patients With Major Depressive Disorder (MDD) Who Have Had an Inadequate Response to Antidepressants Alone

Who this might be right for
Major Depressive Disorder
AbbVie 759
Next Page